News
-
-
PRESS RELEASE
VALBIOTIS SA: Valbiotis publishes its interim financial statements and confirms its roadmap
Valbiotis publishes its interim financial statements, confirms roadmap with successful commercialization, cash position of €13.2M, and growth drivers for 2026. Increased engagement with partners and all financial ambitions through 2030 affirmed -
PRESS RELEASE
VALBIOTIS SA: Valbiotis publishes its interim financial statements and confirms its roadmap
Valbiotis publishes interim financial results with robust commercialization timeline, solid cash position and growth drivers activated, while confirming financial ambitions through 2030. International engagements with partners intensify -
-
-
-
-
-
-
PRESS RELEASE
VALBIOTIS SA: Valbiotis announces the success of its €6.9 million rights issue entirely dedicated to supporting the commercial expansion of its offering of dietary supplements
Valbiotis successfully completes €6.9 million rights issue to enhance commercial expansion of dietary supplements. Sébastien Peltier shows renewed commitment